ANVS סך נכסי הפעילות העסקית Annovis Bio Inc

The stable management of Annovis Bio, Inc. (ANVS) is focused on the successful completion of neurological drug trials. This chart of the company's price action demonstrates total assets at 21.74. The business relies on synergy with medical centers in the study of dementia and tremors, while the development strategy is based on a green chemistry approach and strict adherence to ethical standards when working with biomaterials.

Attracting the neuroscience elite to combat Alzheimer's disease requires significant resources, which are accumulated within the balance sheet structure of Annovis Bio, Inc. (ANVS). The trend in total assets, derived reverse-engineered through ROA, demonstrates the aggregate value of assets and liabilities, allowing investors to assess the fundamental strength of Annovis Bio, Inc. (ANVS) and its capacity to sustain costly scientific research and development.